Skye Bioscience, Inc. (SKYE)
NASDAQ·Healthcare·Biotechnology
$0.79
-0.79%
Mkt Cap $37.23M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
Implied Upside
+1412.9%
Consensus $12.00 vs current $0.79
NASDAQ·Healthcare·Biotechnology
$0.79
-0.79%
Mkt Cap $37.23M
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
+1412.9%
Consensus $12.00 vs current $0.79